These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

826 related items for PubMed ID: 16033782

  • 1. The evolution and pathology of frontotemporal dementia.
    Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG.
    Brain; 2005 Sep; 128(Pt 9):1996-2005. PubMed ID: 16033782
    [Abstract] [Full Text] [Related]

  • 2. Pick Complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy.
    Kertesz A.
    Neurologist; 2003 Nov; 9(6):311-7. PubMed ID: 14629785
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, Parisi JE, Dickson DW.
    Neurology; 2006 Jan 10; 66(1):41-8. PubMed ID: 16401843
    [Abstract] [Full Text] [Related]

  • 4. The diagnosis and course of frontotemporal dementia.
    Kertesz A, Blair M, McMonagle P, Munoz DG.
    Alzheimer Dis Assoc Disord; 2007 Jan 10; 21(2):155-63. PubMed ID: 17545742
    [Abstract] [Full Text] [Related]

  • 5. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.
    Snowden JS, Thompson JC, Stopford CL, Richardson AM, Gerhard A, Neary D, Mann DM.
    Brain; 2011 Sep 10; 134(Pt 9):2478-92. PubMed ID: 21840888
    [Abstract] [Full Text] [Related]

  • 6. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J, Shaw CL, Du Plessis D, Richardson AM, Bailey KL, Julien C, Stopford C, Thompson J, Varma A, Craufurd D, Tian J, Pickering-Brown S, Neary D, Snowden JS, Mann DM.
    Acta Neuropathol; 2005 Nov 10; 110(5):501-12. PubMed ID: 16222525
    [Abstract] [Full Text] [Related]

  • 7. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
    Kertesz A, Munoz D.
    Dement Geriatr Cogn Disord; 2004 Nov 10; 17(4):282-6. PubMed ID: 15178937
    [Abstract] [Full Text] [Related]

  • 8. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I, Barrachina M, Puig B.
    Acta Neuropathol; 2002 Dec 10; 104(6):583-91. PubMed ID: 12410379
    [Abstract] [Full Text] [Related]

  • 9. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T, Ikeda K, Akiyama H, Tsuchiya K, Iritani S, Ishiguro K, Yagishita S, Oda T, Odawara T, Iseki E.
    Acta Neuropathol; 2003 May 10; 105(5):489-98. PubMed ID: 12677450
    [Abstract] [Full Text] [Related]

  • 10. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, Raju S, Matsui T, Growdon JH, Frosch MP, Ghetti B, Brown RH, Irizarry MC, Hyman BT.
    Acta Neuropathol; 2007 Nov 10; 114(5):471-9. PubMed ID: 17721707
    [Abstract] [Full Text] [Related]

  • 11. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
    Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, Hahn-Barma V, van der Zee J, Clot F, Bakchine S, Puel M, Ghanim M, Lacomblez L, Mikol J, Deramecourt V, Lejeune P, de la Sayette V, Belliard S, Vercelletto M, Meyrignac C, Van Broeckhoven C, Lambert JC, Verpillat P, Campion D, Habert MO, Dubois B, Brice A, French research network on FTD/FTD-MND.
    Brain; 2008 Mar 10; 131(Pt 3):732-46. PubMed ID: 18245784
    [Abstract] [Full Text] [Related]

  • 12. Education plays a different role in Frontotemporal Dementia and Alzheimer's disease.
    Borroni B, Alberici A, Agosti C, Premi E, Padovani A.
    Int J Geriatr Psychiatry; 2008 Aug 10; 23(8):796-800. PubMed ID: 18172915
    [Abstract] [Full Text] [Related]

  • 13. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
    Kertesz A, McMonagle P.
    J Neurol Sci; 2010 Feb 15; 289(1-2):138-43. PubMed ID: 19733862
    [Abstract] [Full Text] [Related]

  • 14. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology.
    Rippon GA, Boeve BF, Parisi JE, Dickson DW, Ivnik RI, Jack CR, Hutton M, Baker M, Josephs KA, Knopman DS, Petersen RC.
    Neurocase; 2005 Jun 15; 11(3):204-11. PubMed ID: 16006341
    [Abstract] [Full Text] [Related]

  • 15. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration?
    Tan CF, Piao YS, Kakita A, Yamada M, Takano H, Tanaka M, Mano A, Makino K, Nishizawa M, Wakabayashi K, Takahashi H.
    Acta Neuropathol; 2005 Mar 15; 109(3):329-38. PubMed ID: 15841415
    [Abstract] [Full Text] [Related]

  • 16. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA.
    Neurodegener Dis; 2008 Mar 15; 5(6):339-46. PubMed ID: 18349518
    [Abstract] [Full Text] [Related]

  • 17. Frontotemporal dementia.
    Graff-Radford NR, Woodruff BK.
    Semin Neurol; 2007 Feb 15; 27(1):48-57. PubMed ID: 17226741
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology.
    Pickering-Brown SM, Owen F, Isaacs A, Snowden J, Varma A, Neary D, Furlong R, Daniel SE, Cairns NJ, Mann DM.
    Exp Neurol; 2000 Jun 15; 163(2):452-6. PubMed ID: 10833320
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA, Love S.
    J Neuropathol Exp Neurol; 2007 Nov 15; 66(11):1019-26. PubMed ID: 17984683
    [Abstract] [Full Text] [Related]

  • 20. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B, Malinverno M, Gardoni F, Alberici A, Parnetti L, Premi E, Bonuccelli U, Grassi M, Perani D, Calabresi P, Di Luca M, Padovani A.
    Neurology; 2008 Nov 25; 71(22):1796-803. PubMed ID: 18971445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.